-
Abstract Number: OC 39.2
Nanomedicine Targeting to Activated Neutrophils and Neutrophil-platelet Complexes Provides Effective Thromboprotection
-
Abstract Number: PB0274
National Survey about Management of Venous Thromboembolism (VTE) Prevention in COVID-19 Patients in Uruguay
-
Abstract Number: PB1201
National Survey of Hospital–associated Venous Thromboembolism Prevention in NHS England: Findings from the GIRFT Thrombosis Survey
-
Abstract Number: PB1268
Nationwide Children’s Hospital Pediatric and Adult Comprehensive Anticoagulation Program: A Report on its Anticoagulation Management and Clinical Outcomes
-
Abstract Number: PB0950
Nationwide Screening Programme for Bleeding Disorders Among Adolescent Girls
-
Abstract Number: PB0749
Native Rotational Thromboelastometry in Chemotherapy Induced Thrombocytopenia
-
Abstract Number: PB0290
Native Rotational Thromboelastometry Observations in Critically Ill COVID-19 Patients
-
Abstract Number: PB0132
Natural Anticoagulants from Peonies
-
Abstract Number: PB0014
Natural Changes in CHA2DS2-VASc Scores in Newly Diagnosed Non-valvular Atrial Fibrillation Patients with Low Stroke Risk
-
Abstract Number: PB0391
Natural Fluorescence of Thrombin Substrate Z-Gly-Gly-Arg 7-amino-4-methylcoumarin: Considerations for Wavelength Choice
-
Abstract Number: OC 20.1
NEOCLOT: Management of Catheter-related Venous Thrombosis in Preterm and Term Neonates
-
Abstract Number: PB0951
Neurosurgery in a Patient with von Willebrand Disease: A Case-report
-
Abstract Number: PB1259
Neutralization of the Anticoagulant Effects of Sulodexide by Protamine Sulfate
-
Abstract Number: PB1253
Neutralization of the Oral and Parenteral Anti-Xa Agents by Andexanet Alfa
-
Abstract Number: OC 24.2
Neutralizing and Non-neutralizing Anti-FVIII Antibodies in Black and White Hemophilia A Subjects: A Natural History Profile
-
Abstract Number: LPB0038
Neutrophil Binding on E-selectin: a Potential Biomarker of Clinical Course and Response to Therapy in Sickle Cell Disease
-
Abstract Number: OC 15.3
Neutrophil Extracellular Traps in COVID-19 Patients Correlates with Therapy, Disease Severity and Mortality
-
Abstract Number: LPB0037
Neutrophil Extracellular Traps in Thrombosis of Ovine Extracorporeal Membrane Oxygenation Models
-
Abstract Number: PB0118
Neutrophils Can Promote Clotting by Secreting Proteins that Activate FXI while NETs Promote Clotting Independently of FXI in vitro
-
Abstract Number: PB0119
Neutrophils Promote Tissue Factor-dependent Thrombin Generation in the Absence of Platelets
-
Abstract Number: PB1299
New Criteria for Assessing Hemostasis Disorders in Pregnant Women with Chronic Kidney Disease
-
Abstract Number: PB0483
New Likely Pathogenic Variants in Three Spanish Patients with Mild Hemophilia A and B: Importance of Genetic Counseling
-
Abstract Number: PB0985
New Strategies for Minimization of Surface-induced Platelet Activation
-
Abstract Number: OC 39.3
New strategy to improve the detection of large neutrophil-derived extracellular vesicles in plasma by fluo-sensitive flow cytometry
-
Abstract Number: PB0036
New Thromboplastin-based Modification of Thromboembolic Ischemic Stroke Model in Rats
-
Abstract Number: PB0329
Newly Developed Dilute Russell’s Viper Venom Reagents for Lupus Anticoagulant Detection
-
Abstract Number: PB0381
Newly Developed Ellagic Acid Based APTT Reagent Showed High Lupus Anticoagulant Sensitivity
-
Abstract Number: PB0359
Next Generation Sequencing in Patients with Bleeding, Thrombotic and Platelet Disorders: A Single Centre Experience
-
Abstract Number: OC 55.4
No Difference in Inhibitor Incidence in Previously Untreated Patients (PUPs) with Severe and Moderately Severe Hemophilia A Treated with a Third-generation Recombinant Factor VIII when Compared with Plasma-derived Factor VIII
-
Abstract Number: PB1172
Non-malignant Portal Vein Thrombi in Patients with Cirrhosis Consist of Intimal Fibrosis with or without a Fibrin-rich Thrombus
-
Abstract Number: PB0066
Non-thrombogenic Effect Observed with Simulated Concomitant Administration of Anti-hemophilic Factor, Emicizumab and rFVIIa on Thrombin Generation
-
Abstract Number: PB0891
Noonan Syndrome Bleeding Diathesis: Coagulation Factor Deficiencies and/or Platelet Function Disorders?
-
Abstract Number: PB0352
Normal Values in Thrombin Generation Parameters in Hemorraghic Diseases
-
Abstract Number: PB1313
Not Yet to Be Born: A Clinical Case of Pseudothrombocytopenia in a Pregnant Woman
-
Abstract Number: PB0657
Novel Hyperactive FIX Variants and their Potential for Hemophilia B Therapy
-
Abstract Number: PB1306
Novel Point of Care Rapid Coagulation Analyzer for Obstetrics – Quantra (SEER Sonorheometry)
-
Abstract Number: OC 40.4
Novel, Point-of-Care Coagulation Test Detects Anticoagulation Resistance Predictive of Thrombotic Events in Pediatric ECMO Patients
-
Abstract Number: PB0436
NSAIDs prescription use and subsequent risk of upper gastrointestinal bleeding: a time-trend analysis
-
Abstract Number: LPB0101
Nucleotides Inhibit Serine Proteases Involved in Blood Clotting and Other Cellular Processes
ISTH 2021 Congress
July 17-21, 2021. Philadelphia, PA.